2024 annual financial data
Propanc Biopharma 2024 Net income growth
Direct answer
Net income growth was 31.57%.
Operating income was -1,536,000 USD and net income was -1,821,000 USD.
Operating cash flow was -935,118 USD.
Get free Propanc Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,536,000 USD
- Net income
- -1,821,000 USD
- Operating cash flow
- -935,118 USD